Compile Data Set for Download or QSAR
maximum 50k data
Found 43 Enz. Inhib. hit(s) with all data for entry = 6023
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104507(US8575114, III-2)
Affinity DataIC50:  11.4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104509(US8575114, III-4)
Affinity DataIC50:  23.6nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104500(US8575114, I-12)
Affinity DataIC50:  36.6nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104496(US8575114, I-8)
Affinity DataIC50:  81.1nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104489(US8575114, I-1)
Affinity DataIC50:  82.8nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104508(US8575114, III-3)
Affinity DataIC50:  83nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104492(US8575114, I-4)
Affinity DataIC50:  91nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104498(US8575114, I-10)
Affinity DataIC50:  94.8nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104497(US8575114, I-9)
Affinity DataIC50:  109nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104490(US8575114, I-2)
Affinity DataIC50:  129nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104494(US8575114, I-6)
Affinity DataIC50:  145nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104508(US8575114, III-3)
Affinity DataIC50:  148nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104502(US8575114, I-14)
Affinity DataIC50:  170nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104499(US8575114, I-11)
Affinity DataIC50:  222nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104501(US8575114, I-13)
Affinity DataIC50:  223nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104504(US8575114, II-1)
Affinity DataIC50:  226nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104491(US8575114, I-3)
Affinity DataIC50:  273nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104495(US8575114, I-7)
Affinity DataIC50:  316nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104506(US8575114, III-1)
Affinity DataIC50:  329nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104503(US8575114, I-15)
Affinity DataIC50:  463nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104510(US8575114, III-5)
Affinity DataIC50:  489nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104505(US8575114, II-2)
Affinity DataIC50:  542nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104493(US8575114, I-5)
Affinity DataIC50:  991nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104506(US8575114, III-1)
Affinity DataIC50:  6.25E+3nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104507(US8575114, III-2)
Affinity DataIC50:  1.75E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104489(US8575114, I-1)
Affinity DataIC50:  2.42E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104509(US8575114, III-4)
Affinity DataIC50:  3.54E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104498(US8575114, I-10)
Affinity DataIC50:  4.56E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104491(US8575114, I-3)
Affinity DataIC50:  4.95E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104496(US8575114, I-8)
Affinity DataIC50:  6.12E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104490(US8575114, I-2)
Affinity DataIC50:  6.74E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104505(US8575114, II-2)
Affinity DataIC50:  7.15E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104495(US8575114, I-7)
Affinity DataIC50: >7.32E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104504(US8575114, II-1)
Affinity DataIC50: >9.00E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104492(US8575114, I-4)
Affinity DataIC50: >9.00E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104510(US8575114, III-5)
Affinity DataIC50: >9.00E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104503(US8575114, I-15)
Affinity DataIC50: >9.00E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104493(US8575114, I-5)
Affinity DataIC50: >9.00E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104501(US8575114, I-13)
Affinity DataIC50: >9.00E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104500(US8575114, I-12)
Affinity DataIC50: >9.00E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104497(US8575114, I-9)
Affinity DataIC50:  9.00E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104494(US8575114, I-6)
Affinity DataIC50: >9.00E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM104502(US8575114, I-14)
Affinity DataIC50: >9.00E+4nMAssay Description:The inhibitory activity of the compounds of this invention against the SGLT-1 or SGLT-2 transporters.More data for this Ligand-Target Pair
In DepthDetails US Patent